Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Early pregnancy blood pressure patterns tied to hypertension risk years later
Researchers show certain blood pressure patterns during the first 20 weeks of pregnancy were more likely to develop into hypertension later in life.
Heart Rhythm Society legislative advocacy group raising funds for electrophysiology
This week, Heart Rhythm Advocates announced its establishment and called on cardiologists and EPs to support its efforts with membership and joining committees to guide efforts.
Key takeaways from ACC.25: Advances in cardiovascular science
Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.
New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.

ACC.24, the annual meeting of the American College of Cardiology (ACC), kicked off on Saturday, April 6, with a series of late-breaking clinical trials focused on testing the safety and effectiveness of new treatment strategies.

The biggest names in TAVR are sharing new data at ACC.25

The country’s two biggest TAVR vendors both plan on making a splash at ACC.25. Medtronic and Edwards Lifesciences spoke to Cardiovascular Business about their plans for the three-day event in Chicago.

New PET imaging method could improve our understanding of long COVID

Researchers have developed a new radiotracer that targets one of the virus’ spike proteins, allowing them to track it longitudinally.

Laxmi Mehta explaining statins are no longer contraindicated for pregnant women

Is statin therapy safe for pregnant women?

Laxmi Mehta, MD, explained that the use of statins when treating pregnant women is no longer forbidden. However, she added, cardiologists should always discuss it first with their patients.

Inspiris Resilia aortic valve from Edwards Lifesciences

First-in-class SAVR valve from Edwards Lifesciences linked to positive 5-year outcomes

Researchers focused on a relatively young patient population, hoping to learn as much as possible about the surgical valve's safety and effectiveness over an extended period of time.

First human X-rays in space to take place during upcoming SpaceX mission

Specialized portable imaging equipment will be deployed to study the impact of spaceflight on the human body.

Surgeons transplanting a pig heart into a human patient.

Heart transplants at VA medical center shut down after patient deaths

Safety incidents extend the halt at Richmond VA Medical Center into its 19th month, as the United Network for Organ Sharing launches its own investigation following an internal probe by Veterans Affairs.

FDA approves vutrisiran to treat ATTR-CM

The subcutaneous drug, sold under the brand name Amvuttra, joins an ATTR-CM market that already includes Pfizer’s tafamidis (Vyndaqel, Vyndamax) and BridgeBio’s acoramidis (Attruby).

Abbott makes IVL move as FDA approves new clinical trial

Abbott has received an investigational device exemption from the FDA for a new clinical trial evaluating the safety and effectiveness of using its coronary IVL technology. The trial is expected to enroll up to 335 U.S. patients.

Clinical

Early pregnancy blood pressure patterns tied to hypertension risk years later

Heart Rhythm Society legislative advocacy group raising funds for electrophysiology

Key takeaways from ACC.25: Advances in cardiovascular science

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure